Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

IFS Announces the Launch of the Copperleaf Accelerate Program

Unveiled at IFS Unleashed, the first 25 subscribed customers receive free technical implementationOrlando, FL - IFS UNLEASHED - October 16, 2024 - IFS, the leading provider of enterprise cloud and Industrial AI software, announces the launch of the Copperleaf Accelerate Program. The Program enables IFS customers to transfer operational and tactical asset management data in IFS into Copperleaf’s world leading Asset Investment Planning (AIP) solution, enabling highly strategic investment planning. The off-the-shelf solution benefits IFS customers by quickly and seamlessly

Probi partners with Global BHP BrainTrust and the FINGERS Brain Health Institute to counteract dementia

Probi today announces a research collaboration with the Global BHP BrainTrust and FINGERS Brain Health Institute (FBHI) aimed at reducing dementia risk in women, who account for two-thirds of Alzheimer’s cases. The collaboration is part of the planned FINGERS Plus for Women study."We are thrilled to be part of the FINGERS Plus for Women initiative. This collaboration represents a significant step forward in our commitment to advancing brain health and improving everyday life for people worldwide. By combining our expertise in probiotics with the innovative research approach of the Global

TEXEL Acquires Thermal Energy Technologies from Former Nasdaq-Listed AZELIO

TEXEL Energy AB (“TEXEL”), a world leader in thermal energy-to-electricity technology, has today announced the acquisition of all Stirling engine releated assets to the “Gas-Box” development from former Nasdaq-listed Azelio AB. This strategic acquisition further strengthens TEXEL’s position in converting various heat sources into electricity.In addition to the Stirling engine technology, TEXEL has also acquired the full developed thermal energy storage technology from Azelio, broadening the company's technological portfolio. Azelio has been investing aproximatly $400 million in R&D over the

ExpreS2ion and Serum Institute of India have entered in a term sheet regarding proposed development and commercialisation of novel malaria vaccines

Hørsholm, Denmark, 16 October 2024 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion"), a clinical-stage biotechnology company with a focused pipeline of vaccine candidates targeting infectious diseases and cancer, announces that a term sheet has been entered with Serum Institute of India Private Limited (“SIIPL”), the world’s largest vaccine manufacturer. Upon execution of a definitive agreement on terms to be mutually agreed, SIIPL will obtain exclusive licensing rights to develop, manufacture, and commercialise certain malaria vaccine product lines,

Stora Enso comments on postponement of payments to suppliers

STORA ENSO OYJ PRESS RELEASE 16 October 2024 at 14:15 EESTAs announced on 14 October , Stora Enso has postponed payments to some suppliers by one week in the last weeks of June and September this year. These were extraordinary actions with the objective to optimise cash flow. A decision has been made to not postpone quarter end payments to suppliers going forward. Postponed invoice payments have been made. “We value our suppliers, which are

Nomination Committee appointed for Beijer Ref AB:s Annual General Meeting 2025

In accordance with the decision by the Annual General Meeting, Beijer Ref Nomination Committee shall consist of five members. The members should be one representative of each of the five largest shareholders in terms of voting rights based on the known shareholding as per the last trading day in August, that wish to participate in the committee. This year’s Nomination Committee consists of the following members: Juho Frilander (EQT)Joen Magnusson (own and related parties’ holdings)Per Bertland (own and related parties’ holdings)Vegard Torsnes (Norges Bank)Patricia Hedelius (

Presentation of 3[rd] quarter 2024 results

Atea ASA will present its 3[rd] quarter 2024 financial results on Wednesday, 23 October 2024 at 08:00 CEST. The presentation will be held at Thon Hotel Vika Atrium, Munkedamsveien 45, Oslo, Norway. In addition to presenting the 3[rd] quarter 2024 results, the company will provide an update on the business. The quarterly report, presentation material, and webcast will be available at:https://www.atea.com/financial-reports/ For further information, please contact:Robert Giori, CFO, Atea ASA, mobile (+47) 934 09 188  About AteaAtea is the leading supplier of IT

Arctic Bioscience – Mandatory notification of trade

Runhild Gammelsæter, Medical Director at Arctic Bioscience, has today bought 10,000 shares in Arctic Bioscience at an average price of NOK 2,86 per share. Following the transaction, Runhild Gammelsæter holds 34,774 shares in Arctic Bioscience.Please refer to the attached notification of trading for further details.  This information is subject to the disclosure requirements pursuant to Regulation EU 596/2014 (MAR) article 19 number 3 and the Norwegian Securities Trading Act § 5-12.

Net Asset Value(s)

Miton UK MicroCap Trust plc 16[th] October 2024Miton UK Microcap Trust plc It is announced that at the close of business on 15[th] October 2024, the unaudited Net Asset Value per share of Miton UK Microcap Trust plc is: With the portfolio valued on a fair value basis: Including current period revenue to 15[th] October 2024                                       51.25p per ordinary share Excluding current period revenue               51.17p per ordinary share Legal Entity Identifier 21380048Q8UABVMAG916 16[th] October 2024

Nexam Chemical secures first full scale production order from key global customer

Nexam Chemical, a leader in innovative additives that enhance the properties and performance of polymers, today announces a first full scale production order from a global manufacturer of "Structural composites".This order follows close to two years of intensive research and development, resulting in the first large-scale production order. The collaboration marks a substantial step forward with a leading global customer that has substantial business in the structural composites field. Ronnie Törnqvist, CEO of Nexam Chemical, commented: "Over one and a half years of intensive development

265 nominees for the 2025 Astrid Lindgren Memorial Award

A total of 265 candidates from 72 countries and regions have been nominated for the 2025 Astrid Lindgren Memorial Award, including 81 candidates new from previous years. The list of nominees is one of the most complete rosters of the leading children’s book creators and reading promoters from around the world. The laureate will be announced on 1 April 2025.– All children have the right to great stories. That is why it is pleasing to have so many new candidates on the list, but above all, that they come from more countries than last year. For anyone interested in children's and young adult

Skanska one of world’s best employers once again, says Forbes

Skanska has been ranked by business magazine Forbes as one of the world’s best employers for the third year running. The exclusive “World’s Best Employers” list is based on surveys with more than 300,000 employees working for multinational companies and institutions in over 50 countries.The ranking confirms that Skanska provides a dynamic workplace where people can learn, develop and make a difference, says Anders Danielsson, President and CEO at Skanska Group. “It reflects the work we have been doing to attract and retain the best people and teams in the industry,” says Anders

Another three centers under the French Unicancer framework select RayStation

RaySearch Laboratories AB (publ) is pleased to announce that Institut de Cancérologie de Lorraine, Centre Jean Perrin, and Centre Hospitalier Universitaire de Limoges, have placed orders for the treatment planning system RayStation®* under the Unicancer 2019 Framework agreement.Unicancer is a French hospital network exclusively specialized in oncology. It brings together 18 comprehensive cancer centers and two affiliated centers, spread across 22 hospitals in France. Annually, more than 600,000 patients are treated at a Unicancer center and across the network, 787 clinical trials are

Announcement of a Change in Shareholding According to Chapter 9, Section 10 of the Finnish Securities Market Act

Sitowise Group Plc Stock Exchange Release 16 October 2024 at 12.30 p.m. (EEST) Sitowise Group Plc (the "Company") has on 15 October 2024 received a notification in accordance with the Chapter 9, Section 10 of the Finnish Securities Market Act from Morgan Stanley, according to which Morgan Stanley & Co International Plc's holding of the shares and votes of the Company has increased to 11.16 percent on 14 October 2024. According to the notification, Morgan Stanley holds indirectly a total of 2,920,915 shares corresponding to 8.15 percent of the Company’s shares and votes, and a total of

BioStock: Prolight eyes business opportunity for plasma separation method

Prolight Diagnostics has secured European patent approval for its method for separating plasma from whole blood, utilized in the MicroFlex system. This separation technology presents a business opportunity as it can be integrated into other systems and adapted for use with various sample types. To gain deeper insights into the technology, BioStock contacted the company’s development partner, TTP.Read the full article at biostock.se :https://www.biostock.se/en/2024/10/prolight-eyes-business-opportunity-for-plasma-separation-method/ This is a press release

Profit warning, inside information: UPM lowers its outlook due to lower deliveries in most businesses and decreased pulp prices

UPM-Kymmene Corporation Stock Exchange Release (Inside information) 16 October 2024 at 12:00 EEST Profit warning, inside information: UPM lowers its outlook due to lower deliveries in most businesses and decreased pulp prices UPM lowers its outlook for 2024 and releases its preliminary Q3 2024 results. During the second half of the year, UPM’s earnings have improved, however less than earlier expected. Comparable EBIT in Q3 2024 increased by 32% to EUR 291 million from Q3 2023, and 17% for the first nine months compared to last year. Comparable EBIT in Q4 2024 is expected to be on

Arctic Bioscience – Mandatory notification of trade

Gold Coast Nutrition, a legal person closely associated with a person discharging managerial responsibility in Arctic Bioscience, has today bought 5,000 shares in Arctic Bioscience at an average price of NOK 3,00 per share. Following the transaction, Gold Coast Nutrition holds 460,000 shares in Arctic Bioscience.CSO at Arctic Bioscience, Hogne Hallaråker, is the owner of Gold Coast Nutrition. Please refer to the attached notification of trading for further details.  This information is subject to the disclosure requirements pursuant to Regulation EU 596/2014 (MAR) article 19 and the

Outokumpu publishes its January-September interim report and arranges a webcast on October 30, 2024

Outokumpu CorporationPress releaseOctober 16, 2024 at 11.00 am EESTOutokumpu will publish its interim report for January-September 2024 on Wednesday, October 30, 2024 at approximately 9.00 am EET. A live webcast and conference call to analysts, investors and representatives of media will be arranged later on the same day, at 3.00 pm EET at https://outokumpu.videosync.fi/q3-2024 hosted by President and CEO Kati ter Horst and CFO Marc-Simon Schaar. To ask questions, please participate in the conference call by registering at https://palvelu.flik.fi/teleconference/?id=50049025. After

Cessatech announces that recruitment has today reached the halfway point for patient recruitment with 75 included patients in the Paediatric Study 0202

· 75 paediatric patients have now been recruited in Study 0202 · Study 0202 is the final required clinical study that will evaluate the safety and efficacy profile for CT001 in children · CT001 is a nasal spray for the treatment of acute pain in childrenOn 16 October – Cessatech A/S (“Cessatech” or “the Company”) announces that it has reached the halfway point for patient recruitment of its final study Paediatric Study 0202 in the development program of 0202. Study 0202 is the final required clinical study that will evaluate the safety and efficacy profile for CT001 in 150 children.

CasinoRank Launches New Podcast "iGaming Pulse" – Your Source for iGaming News and Trends

Stockholm, October 16, 2024 – CasinoRank is excited to introduce iGaming Pulse, a brand-new podcast created to keep listeners informed about the latest news, trends, and developments in the iGaming industry. Whether you're a gaming enthusiast or someone working within the industry, iGaming Pulse delivers straightforward, engaging conversations and expert insights that are easy to follow.Although the podcast has just launched, iGaming Pulse is set to grow rapidly, with plans to expand into more topics and feature a broader range of expert interviews. In each episode, listeners can expect

Salsa to Present Award-winning Tech Solutions for Latam’s Regulated Markets at SBC Summit Latinoamérica

Salsa Technology is heading to SBC Summit Latinoamérica where it will be available to present its solutions that are already active and producing results in the regulated Brazilian market. The special event is being held between October 29th and October 31st at the Seminole Hard Rock Hotel & Casino and is a must for those companies seeking to expand their reach in the region.An integral part of Salsa’s LatAm-focused solutions is the innovative Salsa Omni (PAM) platform, certified by GLI. With its robust and comprehensive back office, it provides an unmatched level of autonomy for operators

Big Akwa Opens new Investment Round to Drive the Future of circular foodproduction

Big Akwa, a Swedish food-tech company developing a land-based aquaculture project with an annual capacity of 6000 tons at Alby industrial park in mid Sweden, announces the opening of new investment round.The raised capital will be used to continue the development of the planned facility and support the company’s growth strategy. “We look forward to welcoming new and existing investors to join our journey towards efficient and circular food production” says Elena Petukhovskaya, CEO and co-founder. For more information, please contact: Elena Petukhovskaya, CEO Big Akwa AB (publ.)

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 230 – 16 OCTOBER 2024   In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 171/24 and 173/24, respectively. Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Martin Badsted, Chief Financial Officer, tel.: +45 33 42 05 26, e-mail: mba@norden.com

Akastor ASA: Invitation to Presentation of Third Quarter 2024 Results

Akastor ASA invites investors and analysts to a webcast presentation of the third quarter 2024 financial results on Wednesday, 30 October 2024. Date and time:Wednesday, 30 October 2024, at 15:00 CET Presenters: · Akastor: Karl Erik Kjelstad, CEO, and Øyvind Paaske, CFO · HMH: Thomas McGee, CFO, and David Bratton, SVP FP&A and Operational Finance Link to webcast:https://akercreativehub.eventcdn.net/events/akastor-audiocast-q3-2024 Questions can be submitted throughout the streaming event. The presentation material will be published on www.akastor.com and www.newsweb.

There are no items matching the current filter
There are no more items matching the current filter
Back to top